[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB0411166D0 - Treatment for asthma and arthritis - Google Patents

Treatment for asthma and arthritis

Info

Publication number
GB0411166D0
GB0411166D0 GBGB0411166.2A GB0411166A GB0411166D0 GB 0411166 D0 GB0411166 D0 GB 0411166D0 GB 0411166 A GB0411166 A GB 0411166A GB 0411166 D0 GB0411166 D0 GB 0411166D0
Authority
GB
United Kingdom
Prior art keywords
asthma
arthritis
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0411166.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bionovate Ltd
Original Assignee
Bionovate Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionovate Ltd filed Critical Bionovate Ltd
Priority to GBGB0411166.2A priority Critical patent/GB0411166D0/en
Publication of GB0411166D0 publication Critical patent/GB0411166D0/en
Priority to US11/569,212 priority patent/US20080234362A1/en
Priority to CA002567189A priority patent/CA2567189A1/en
Priority to EP05744844A priority patent/EP1758603A1/en
Priority to PCT/GB2005/001885 priority patent/WO2005112960A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB0411166.2A 2004-05-19 2004-05-19 Treatment for asthma and arthritis Ceased GB0411166D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB0411166.2A GB0411166D0 (en) 2004-05-19 2004-05-19 Treatment for asthma and arthritis
US11/569,212 US20080234362A1 (en) 2004-05-19 2005-05-17 Treatment for Asthma and Arthritis and Other Inflammatory Diseases
CA002567189A CA2567189A1 (en) 2004-05-19 2005-05-17 Treatment for asthma and arthritis and other inflammatory diseases
EP05744844A EP1758603A1 (en) 2004-05-19 2005-05-17 Treatment for asthma and arthritis and other inflammatory diseases
PCT/GB2005/001885 WO2005112960A1 (en) 2004-05-19 2005-05-17 Treatment for asthma and arthritis and othe inflammatory diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0411166.2A GB0411166D0 (en) 2004-05-19 2004-05-19 Treatment for asthma and arthritis

Publications (1)

Publication Number Publication Date
GB0411166D0 true GB0411166D0 (en) 2004-06-23

Family

ID=32607582

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0411166.2A Ceased GB0411166D0 (en) 2004-05-19 2004-05-19 Treatment for asthma and arthritis

Country Status (5)

Country Link
US (1) US20080234362A1 (en)
EP (1) EP1758603A1 (en)
CA (1) CA2567189A1 (en)
GB (1) GB0411166D0 (en)
WO (1) WO2005112960A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20070555A1 (en) * 2007-03-21 2007-06-20 Giuliani Spa COMPOSITION OF THE ACTIVITY OF INHIBITION ON THE 5 ALPHA-REDUCTASE
EP2848252A3 (en) 2007-03-23 2015-06-17 The Board of Regents of the University of Texas System Aldose reductase inhibitors for use in treating uveitis
EA021514B1 (en) * 2009-05-19 2015-07-30 Унилевер Н.В. Edible product comprising black tea flavonoids and use thereof
FR2948025B1 (en) * 2009-07-15 2013-01-11 Univ Grenoble 1 COMPOSITION COMPRISING POLYPHENOL AND OMEGA-3 FATTY ACID
KR101161707B1 (en) 2010-04-23 2012-07-04 연세대학교 원주산학협력단 Composition for prevention or treatment allergy containing eriodyctiol
EP2392325A1 (en) * 2010-06-04 2011-12-07 Universitätsklinikum Münster Compounds for the prevention and/or treatment of osteoarthrosis
WO2012167226A2 (en) 2011-06-03 2012-12-06 Maguire Abbey, Llc Method, composition, and articles for improving joint lubrication
WO2012177927A1 (en) 2011-06-21 2012-12-27 Mayo Foundation For Medical Education And Research Transgenic animals capable of being induced to delete senescent cells
US20150005382A1 (en) * 2011-10-04 2015-01-01 Wake Forest University Health Sciences (WFUHS) Methods for Identifying and Treating an Individual with an Inflammatory Disease using Fatty Acid-Based Therapies
AU2012352177A1 (en) 2011-12-13 2014-07-10 Buck Institute For Research On Aging Methods for improving medical therapies
US20150064137A1 (en) 2012-04-17 2015-03-05 Kythera Biopharmaceuticals, Inc. Use of engineered viruses to specifically kill senescent cells
US20130315843A1 (en) 2012-05-25 2013-11-28 The Procter & Gamble Company Composition for reduction of trpa1 and trpv1 sensations
US9901080B2 (en) 2012-08-23 2018-02-27 Buck Institute For Research On Aging Transgenic mouse having a transgene that converts a prodrug into a cytotoxic compound in senescent cells
US9901081B2 (en) 2012-08-23 2018-02-27 Buck Institute For Research On Aging Transgenic mouse for determining the role of senescent cells in cancer
TWI671014B (en) 2012-11-26 2019-09-11 美商通路實業集團國際公司 Antioxidant dietary supplement and related method
WO2014089124A1 (en) 2012-12-03 2014-06-12 Cenexys, Inc. Immunogenic compositions for inducing an immune response for elimination of senescent cells
CN103381152A (en) * 2013-02-05 2013-11-06 吉林省金梓源生物科技有限公司 Application of myricetin used as cathepsin K inhibitor
WO2015116735A1 (en) * 2014-01-28 2015-08-06 Mayo Foundation For Medical Education And Research Methods and combinations for killing senescent cells and for treating senescence-associated diseases and disorders
US10328058B2 (en) 2014-01-28 2019-06-25 Mayo Foundation For Medical Education And Research Treating atherosclerosis by removing senescent foam cell macrophages from atherosclerotic plaques
WO2015116740A1 (en) 2014-01-28 2015-08-06 Buck Institute For Research On Aging Methods and compositions for killing senescent cells and for treating senescence-associated diseases and disorders
US10385034B2 (en) * 2014-09-05 2019-08-20 The Cleveland Clinic Foundation Flavonoid IL-17A inhibitors
US11198972B2 (en) 2016-10-25 2021-12-14 The Procter & Gamble Company Fibrous structures
WO2018081190A1 (en) 2016-10-25 2018-05-03 The Procter & Gamble Company Fibrous structures
AU2017380471B2 (en) * 2016-12-23 2023-12-21 Mm Health Ltd Topical formulation comprising green lipped mussel and honey
US20180344685A1 (en) * 2017-06-02 2018-12-06 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Compositions and methods for increased glucose uptake and fat metabolism
IT201700075637A1 (en) 2017-07-05 2019-01-05 Vera Salus Ricerca S R L COMPOSED FOR THE CARE OF MALIGNANT CANCERS
US11654163B2 (en) 2017-12-22 2023-05-23 Pharmalink International Limited Lipid combinations
KR20230116031A (en) * 2020-12-01 2023-08-03 바이오넥사 에스.알.엘 senotherapeutic substances

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931283A (en) * 1983-12-22 1990-06-05 American Home Products Corp. (Del) Menthol enhancement of transdermal drug delivery
US4708964A (en) * 1984-02-09 1987-11-24 Chemex Pharmaceuticals Lipoxygenase inhibitors
US4584320A (en) * 1985-01-03 1986-04-22 David Rubin Anti-asthmatic composition and method using 8,11,14,17-eicosatetraenoic acid
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
JPH06505959A (en) * 1990-05-07 1994-07-07 ボッコー　バリー　アイ Methods and formulations of stable deodorized oils and pharmaceutical compositions thereof
AUPM740594A0 (en) * 1994-08-11 1994-09-01 J.W. Broadbent Nominees Pty. Ltd. Anti-inflammatory preparation
US5914345A (en) * 1994-10-11 1999-06-22 Endoluminal Therapeutics, Inc. Treatment of tissues to reduce subsequent response to injury
AUPN531195A0 (en) * 1995-09-11 1995-10-05 J.W. Broadbent Nominees Pty. Ltd. Lipid extract having anti-inflamatory activity
TW425285B (en) * 1996-06-10 2001-03-11 Viva America Marketing Inc Fish oil and garlic nutritive supplement
US7115278B2 (en) * 1998-04-08 2006-10-03 Theoharis C Theoharides Proteoglycan compositions for the treatment of cardiovascular inflammatory diseases
US6984667B2 (en) * 1998-04-08 2006-01-10 Theta Biomedical Consulting And Development Co. Synergistic proteoglycan compositions for inflammatory conditions
JP2000149283A (en) * 1998-09-04 2000-05-30 Sony Corp Optical head and recording/reproducing device
US6596303B1 (en) * 1999-03-22 2003-07-22 Mars Incorporated Pet food for maintenance of joint health and alleviation of arthritic symptoms in companion animals
IT1306722B1 (en) * 1999-10-08 2001-10-02 Sigma Tau Healthscience Spa COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF CIRCULATORY DYSFUNCTIONS, INCLUDING L-CARNITINE DERIVATIVES AND EXTRACTS OF
AU2002311922A1 (en) * 2001-05-15 2002-11-25 The Procter And Gamble Company Oral care compositions
US6607745B2 (en) * 2001-05-18 2003-08-19 Harry Leneau Ingestion of hyaluronic acid for improved joint function and health
EP1716221B1 (en) * 2004-01-30 2008-11-05 Bionovate Limited Solvent extraction of lipids from perna canaliculus

Also Published As

Publication number Publication date
EP1758603A1 (en) 2007-03-07
CA2567189A1 (en) 2005-12-01
US20080234362A1 (en) 2008-09-25
WO2005112960A1 (en) 2005-12-01

Similar Documents

Publication Publication Date Title
GB0411166D0 (en) Treatment for asthma and arthritis
IL178816A0 (en) The treatment of childhood asthma
HK1098072A1 (en) Medicaments and methods for treating headache
IL228770A0 (en) Processes and intermaediates
EP1757368A4 (en) Gas treatment equipment
GB0822148D0 (en) Methods and apparatus
GB0416917D0 (en) Gas treatment apparatus
HK1120017A1 (en) Biocides and apparatus
ZA200608195B (en) Improved configurations and methods for effluent gas treatment
HK1175117A1 (en) Composition and method for the treatment of asthma symptoms
EP1527196A4 (en) Treatment for asthma or allergies
GB0410471D0 (en) Process and product
IL180365A0 (en) Carboranylporphyrins and uses thereof
EP1753468A4 (en) Carboranylporphyrins and uses thereof
GB0417263D0 (en) Process and system
IL183702A0 (en) Difluoronucleosides and process for preparation thereof
EP1720893A4 (en) Compositions and methods for the systemic treatment of arthritis
EP1838288A4 (en) Therapeutic materials and methods
EP1715825A4 (en) Methods and devices for relieving upper airway obstructions
GB0402629D0 (en) Reactor and process
EP1804703A4 (en) Cryo-surgical apparatus and methods
EP1737788A4 (en) Improved configurations and methods for effluent gas treatment
GB0426141D0 (en) Treatment
EP1737475A4 (en) Herbal therapy for the treatment of asthma
GB0403696D0 (en) Process and composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)